α-Eleostearic acid and its dihydroxy derivative are major apoptosis-inducing components of bitter gourd

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 22, 2008, Pages 10515-10520

  Kobori, Masuko ^a   Ohnishi Kameyama, Mayumi ^a   Akimoto, Yukari ^a   Yukizaki, Chizuko ^b   Yoshida, Mitsuru ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^b Miyazaki Prefectural Food Research and Development Center   (Japan)

Author keywords

eleostearic acid; 15,16 dihydroxy eleostearic acid; Apoptosis; Bitter gourd; Hl60 cells

Indexed keywords

15,16 DIHYDROXY ALPHA ELEOSTEARIC ACID; 15,16-DIHYDROXY ALPHA-ELEOSTEARIC ACID; ELEOSTEARIC ACID; LINOLENIC ACID; PLANT EXTRACT;

ANIMAL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL STRAIN HL 60; CELL STRAIN HT29; CHEMISTRY; DRUG EFFECT; FRUIT; HUMAN; MOMORDICA CHARANTIA; MOUSE; PLANT SEED;

ANIMALS; APOPTOSIS; FRUIT; HL-60 CELLS; HT29 CELLS; HUMANS; LINOLENIC ACIDS; MICE; MOMORDICA CHARANTIA; NEOPLASM TRANSPLANTATION; PLANT EXTRACTS; SEEDS;

MOMORDICA CHARANTIA;

EID: 57849126354     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8020877     Document Type: Article

References (28)

1. Basch, E.; Gabardi, S.; Ulbricht, C. Bitter melon (Momordica charantia): A review of efficacy and safety. Am. J. Health-Syst. Pharm. 2003, 60, 356-359.
2. Grover, J.; Yadav, S. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol. 2004, 93, 123-132.
3. Dans, A.; Villarruz, M.; Jimeno, C.; Javelosa, M.; Chua, J.; Bautista, R.; Velez, G. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J. Clin. Epidemiol. 2007, 60, 554-559.
4. Ahmed, I; Adeghate, E.; Cummings, E.; Sharma, A.; Singh, J. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol. Cell. Biochem. 2004, 261, 63-70.
5. Virdi, J.; Sivakami, S.; Shahani, S.; Suthar, A.; Banavalikar, M.; Biyani, M. Antihyperglycemic effects of three extracts from Momordica charantia. J. Ethnopharmacol. 2003, 88, 107-111.
6. Miura, T.; Itoh, Y.; Iwamoto, N.; Kato, M.; Ishida, T. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Biol. Pharm. Bull. 2004, 27, 248-250.
7. Chen, Q.; Chan, L.; Li, E. Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J. Nutr. 2003, 133, 1088-1093.
8. Senanayake, G.; Maruyama, M.; Shibuya, K.; Sakono, M.; Fukuda, N.; Morishita, T.; Yukizaki, C.; Kawano, M.; Ohta, H. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. J. Ethnopharmacol. 2004, 91, 257-262.
9. Huang, H.; Hong, Y.; Wong, Y.; Chen, Y.; Chyuan, J.; Huang, C.; Chao, P. Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br. J. Nutr. 2008, 99, 230-239.
10. Sridhar, M.; Vinayagamoorthi, R.; Arul Suyambunathan, V.; Bobby, Z.; Selvaraj, N. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br. J. Nutr. 2008, 99, 806-812.
11. Yasuda, M.; Iwamoto, M.; Okabe, H.; Yamauchi, T. Structues of momordicine-I, momordicine-II and momordicine-III the bitter principles in the leaves and vines of Momordica charantia L. Chem. Pharm. Bull. 1984, 32, 2044-2047.
12. Kimura, Y.; Akihisa, T.; Yuasa, N.; Ukiya, M.; Suzuki, T.; Toriyama, M.; Motohashi, S.; Tokuda, H. Cucurbitane-type triterpenoids from the fruit of Momordica charantia. J. Nat. Prod. 2005, 68, 807-809.
13. Murakami, T.; Emoto, A.; Matsuda, H.; Yoshikawa, M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem. Pharm. Bull. 2001, 49, 54-63.
14. Harinantenaina, L.; Tanaka, M.; Takaoka, S.; Oda, M.; Mogami, O.; Uchida, M.; Asakawa, Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem. Pharm. Bull. 2006, 54, 1017-1021.
15. Tan, M.; Ye, J.; Turner, N.; Hohnen-Behrens, C.; Ke, C.; Tang, C.; Chen, T.; Weiss, H.; Gesing, E.; Rowland, A.; James, D.; Ye, Y. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol. 2008, 15, 263-273.
16. Akihisa, T.; Higo, N.; Tokuda, H.; Ukiya, M.; Akazawa, H.; Tochigi, Y.; Kimura, Y.; Suzuki, T.; Nishino, H. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. J. Nat. Prod. 2007, 70, 1233-1239.
17. Kobori, M.; Amemiya, J.; Sakai, M.; Shiraki, M.; Sugishita, H.; Sakaue, N.; Hoshi, Y.; Yukizaki, C. Bitter gourd induces apoptosis in HL60 human leukemia cells and suppresses the production of inflammatory cytokine in RAW264.7 macrophage like cells. Food Sci. Technol. Res. 2006, 53, 408-415.
18. Kobori, M.; Nakayama, H.; Fukushima, K.; Ohnishi-Kameyama, M.; Ono, H.; Fukushima, T.; Akimoto, Y.; Masumoto, S.; Yukizaki, C.; Hoshi, Y.; Deguchi, T.; Yoshida, M. Bitter Gourd suppresses lipopolysaccharide-induced inflammatory responses. J. Agric. Food Chem. 2008, 56, 4004-4011.
19. Etoh, S.; Iwashita, K.; Takei, T.; Yamaki, K.; Shinohara, K.; Kobori, M. Bitter gourd induces apoptosis in cancer cell lines. Nippon Shokuhin Kagaku Kogaku Kaishi 2002, 49, 250-256.
20. Kobori, M. In vitro screening for cancer-suppressive effect of food components. Jpn. Agric. Res. Q. 2003, 37, 159-165.
21. Suzuki, R.; Arato, S.; Noguchi, R.; Miyashita, K.; Tachikawa, O. Occurrence of conjugated linolenic acid in fresh and seed of bitter gourd. J. Oleo Sci. 2001, 50, 753-758.
22. Liu, L.; Hammond, E. G.; Nikolau, B. J. In vivo study of the biosynthesis of α-eleostearic acid in the seed of Momordica charantia L. Plant Physiol. 1997, 113, 1343-1349.
23. Serhan, C. N. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta 1994, 1212, 1-25.
24. Kohno, H.; Yasui, Y.; Suzuki, R.; Hosokawa, M.; Miyashita, K.; Tanaka, T. Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPAR γ expression and alteration of lipid composition. Int. J. Cancer 2004, 110, 896-901.
25. Tsuzuki, T.; Tokuyama, Y.; Igarashi, M.; Nkagawa, K.; Ohsaki, Y.; Komai, M.; Miyazawa, T. α-Eleostearic acid (9Z,11E,13E-18:3) is quickly converted to conjugated linoleic acid (9Z,11E-18:2) in rats. J. Nutr. 2004, 134, 2634-2639.
26. Tsuzuki, T.; Kawakami, Y. Tumor angiogenesis suppression by α-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via peroxisome proliferator-activated receptor γ. Carcinogenesis 2008, 29, 797-806.
27. Tsuzuki, T.; Tokuyama, Y.; Igarashi, M.; Miyazawa, T. Tumor growth suppression by α-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 2004, 25, 1417-1425.
28. Islam, M. A.; Kim, Y. S.; Jang, W. J.; Lee, S. M.; Kim, H. G.; Kim, S. Y.; Kim, J. O.; Ha, Y. L. A mixture of trans, trans conjugated linoleic acid induces apoptosis in MCF-7 human breast cancer cells with reciprocal expression of Bax and Bcl-2. J. Agric. Food Chem 2008, 56, 5970-5976.